A. S. Ciampa

Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab

E. C. Quant, Andrew D. Norden, Jan Drappatz et al. · Neuro-Oncology · 2009 · 173 citations · Full text

Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults

Santosh Kesari, David Schiff, Jan Drappatz et al. · Clinical Cancer Research · 2008 · 160 citations

Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults

Santosh Kesari, David Schiff, John W. Henson et al. · Neuro-Oncology · 2008 · 101 citations · Full text

Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients

Andrew D. Norden, J. R. Di Bartolomeo, Shota Tanaka et al. · Journal of Neuro-Oncology · 2011 · 94 citations

Neuro-oncology, Thrombosis, Concurrent Bevacizumab Therapy +10

Phase I Study of Vandetanib With Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma

Jan Drappatz, Andrew D. Norden, Eric T. Wong et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 82 citations

Neuro-oncology, Radiation Therapy, Glioma +8